Financings Of The Fortnight: Corporate Venture Plays Increased Role In Series A Financings
This article was originally published in The Pink Sheet Daily
Executive Summary
More than one-quarter of biopharma or diagnostic start-ups that raised A rounds in the past 18 months had participation by one or more corporate venture arms. Plus news on recent financings by Esperion Therapeutics, XO1, PTC Therapeutics and Valeant.